Previous close | 41.30 |
Open | N/A |
Bid | 43.00 |
Ask | 46.90 |
Strike | 30.00 |
Expiry date | 2026-01-16 |
Day's range | 41.30 - 41.30 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.